Oneness Biotech Co., Ltd. was notified that Bonvadis, the wound care topical cream has obtained import license in India. New drug name or code: Bonvadis. Purpose: Wound Dressing.

Planned development stages:NA. Current development stage: File application/approved/disapproved/Each of clinical trials (include interim analysis):Regulatory Agent in India has notified Oneness on February 18, 2022 that Bonvadis, the wound care topical cream has been approved for import of medical device by regulatory authority CDSCO in India, registration number is Onenes-TWN/I/MD/012373 and allowed for market distribution in India. Once disapproved by competent authority or each of clinical trials (include interim analysis) results less than statistically significant sense, the risks and the associated measures the Company may occur: NA.

After obtaining official approval or the results (include interim analysis) which are statistically significant, the future strategy: To proceed planning for marketing and distribution. Upcoming development plan: Extensions of indications will be applied. Scheduled completion date: The review timeline is subject to the review process regulated by competent authorities in each country.